scispace - formally typeset
W

Werner Hacke

Researcher at Heidelberg University

Publications -  688
Citations -  93115

Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.

Papers
More filters
Journal ArticleDOI

Thrombolytische Therapie des akuten Schlaganfalls

H. Amiri, +2 more
- 17 Sep 2011 - 
TL;DR: Proximal occlusions of the middle cerebral artery can be treated successfully within the first 6 h from stroke onset by catheter-based intra-arterial administration of plasminogen activator leading to a significant improvement of outcome.
Book ChapterDOI

Epidemiologie und Klassifizierung der Schlaganfälle

Herman-J. Gelmers, +3 more
TL;DR: In this paper, the authors verstehen man die Zahl der Krankheitsfalle zu einem bestimmten Zeitpunkt in einer best-immten Personengruppe.
Book ChapterDOI

Basilaristhrombose — Ischämie des hinteren Kreislaufs — Hirnstammsyndrome

Peter D. Schellinger, +2 more
TL;DR: Ischamien des hinteren Kreislaufs schliesen Infarkte im Versorgungsgebiet der A. basilaris und der Aa.
Journal ArticleDOI

Abstract Number ‐ 7: Final Angiographic, Clinical and Thrombus Composition Results of 1000 Patients in the EXCELLENT Registry

Raul G Nogueira, +32 more
- 01 Mar 2023 - 
TL;DR: In this paper , the authors presented a registry of endovascular clot removal in acute ischemic stroke (AIS) with EmboTrap as the first line mechanical thrombectomy (MT) device, which included collection and analysis of retrieved thrombus material.
Journal ArticleDOI

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Sylvia Haas, +1449 more
- 12 Sep 2022 - 
TL;DR: Higher rates of cardiovascular death in DACH may reflect the higher risk profile of these patients and lower rates of non-haemorrhagic stroke could be associated with increased NOAC use, which was associated with a mismatch of risk-adapted anticoagulation (over-and-undertreatment) in Dach.